Testing Process
US BioTek runs all IgE panels on a sophisticated FDA-approved immunoassay analyzer that utilizes enzyme-amplified chemiluminescence technology. Chemiluminescence provides lower detection limits than conventional ELISA, making it particularly suitable for IgE detection, which can be hard to detect due to its short half-life compared to other immunoglobulins.
Sample Report
Results illustrate reactivity to each antigen, reported in five zones from No Reaction to Extremely High Reaction.
Specimen Requirements
Serum is required for this panel.
